FOR IMMEDIATE RELEASE
European Innovative R&D-based Pharma and Early EDC Adopter
Renews and Extends Use of Leading Clinical Trial Technology
NEW YORK, N.Y. – September 13, 2010 – Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, today announced that European pharmaceutical company Orion has extended its use of Medidata Rave® as its enterprise-wide electronic data capture (EDC) and clinical data management (CDM) system, which Orion successfully brought in-house and deployed for all clinical trials for the past three and a half years.
Orion is an innovative R&D-based pharmaceuticals and diagnostics company with an emphasis on developing medicinal treatments and diagnostic tests for global markets. Orion is developing treatments in central nervous system disorders; oncology and critical care; and respiratory medicine, and has a wide portfolio of marketed brand-name and generic medicines.
Orion originally selected Medidata Rave as its EDC platform after an extensive global search based on its easy-to-use, easy-to-learn and flexible platform; robust capabilities for data cleansing and query capture; and Knowledge Transfer program. As a research-savvy development shop, Orion’s goal was to use Rave on its own for all its trials, across all phases and therapeutic areas. The Orion clinical research team accomplished its goal of bringing the Rave trial functions in-house using the knowledge transfer program in collaboration with Medidata, synchronizing with its own development workflows to create a smooth, rapid process for trial set-up and deployment, and reaping additional benefits across multiple trials.
“Our collaboration with Medidata has allowed us to build a clinical study process that meets our internal goals and preferences while utilizing the most advanced technology available,” said Taru Blom, vice president of development in Orion Corporation Orion Pharma R&D. “We are now able to coordinate and manage our clinical information through quick access to clean, real-time data, with a level of communication among our study teams that enhances our research efforts. We value Medidata’s customer and end user-driven focus, and are excited about their new technology solutions that support Medidata’s vision of an enhanced, optimal clinical development process.”
Orion has been a leader in adopting technology into the drug development process, driving industry interest groups and sharing best practices. Over the past several years, Orion has led the development of the European Medidata User Group (E-MUG), delivered presentations at a range of industry conferences and forums on eClinical aspects and participated in the creation of investigational site surveys to assess current use of EDC on a worldwide basis.
“Orion has proven consistent in its strategy of leveraging clinical development solutions that not only deliver cost, time and resource savings, but also improve the clinical development process,” said Tarek Sherif, chairman and CEO, Medidata Solutions. “Medidata has benefited greatly from our collaboration with the Orion team, and their leadership in the industry is a tribute to their innovation and vision.”
About Orion
Orion is an innovative European R&D based pharmaceuticals and diagnostics company dedicated to treating and preventing disease by discovering and developing innovative medicinal treatments and diagnostic tests for global markets. Orion is engaged in human and veterinary drugs, active pharmaceutical ingredients and diagnostic tests. In 2009, Orion's net sales were EUR 771.5 million. Operating profit was EUR 207.0 million, and the company invested EUR 95 million in pharmaceutical research and development. The number of employees is about 3,100. Orion corporate headquarters are in Espoo, Finland. Orion is listed on NASDAQ OMX Helsinki. For more information, please visit: http://www.orion.fi/en/.
About Medidata Solutions Worldwide
Medidata Solutions (www.mdsol.com) is a leading global provider of SaaS-based clinical development solutions that enhance the efficiency of customers’ clinical trials. For over 10 years, Medidata has consistently brought next-generation innovation to the life science industry to lower the total cost of clinical development through informed trial planning and management, optimized clinical processes and platform interoperability. Medidata’s advanced solutions address key functions throughout the clinical development process including protocol development (Medidata Designer®), trial planning and management (Medidata Grants Manager®, Medidata CRO Contractor®), user and learning management (iMedidata™), randomization and trial supply management (Medidata Balance™), monitoring (Medidata Rave Monitor, Medidata Rave Targeted SDV), Serious Adverse Events capture (Medidata Rave Safety Gateway) and clinical data capture, management and reporting (Medidata Rave®). Our diverse customer base spans biopharmaceutical companies, medical device and diagnostic companies, academic and government institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies as well as organizations of all sizes developing life-enhancing medical treatments and diagnostics.
Contact:
Susan McCarron
Lois Paul & Partners
781.782.5767
Susan_McCarron@lpp.com